Ask AI
ProCE Banner Activity

TROP-2 Overview in NSCLC: Expression, Significance, and Therapeutic Rationale

Slideset

Download these slides on the evolving treatment landscape of advanced NSCLC with a focus on the rationale for targeting TROP-2 and the potential role of TROP-2-targeting ADCs.

Released: April 25, 2024

Expiration: April 24, 2025

Review Activity

Share

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by educational grants from AstraZeneca and Daiichi Sankyo, Inc.

AstraZeneca

Daiichi Sankyo, Inc.